Home » Topics » BioWorld

BioWorld
RSS

DNAP TO TEST-MARKET TOMATO

Aug. 2, 1992

CALGENE CLONES REDUCTASE GENE

Aug. 2, 1992

SERAGEN LIKES VIEW FROM THE CLINIC

Aug. 2, 1992

SHAMAN RAISES $10 MILLION IN VC FINANCING

Aug. 2, 1992

DYNAGEN GRANTS RIGHTS TO TB TESTS

Aug. 2, 1992

APPOINTMENTS AND ADVANCEMENTS

July 31, 1992

EVOLUTION IN FAST-FORWARD

July 31, 1992

AIDS AUTHORITY'S VIEW OF CONFERENCE

July 31, 1992

ELECTRIC AVENUE TO DRUG DELIVERY

July 31, 1992

AMEX FOLLOWS RISING DOW

July 30, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...